Image For Activity Cover
GREQH2EM2401 - CME/CMLE - HER2 Testing in Advanced Gynecologic Cancers
Course Description

HER2 Testing in Advanced Gynecologic Cancers 

Activity Description: 

This activity is designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of the latest evidence regarding HER2 testing in advanced gynecologic cancers such as ovarian, cervical, and endometrial cancers.    

Provided by the American Society for Clinical Pathology in partnership with Q Synthesis LLC. 

Activity Agenda  

  • Review of recent updates in pan-tumor HER2 testing and targeted therapy  
  • HER2 testing in ovarian, cervical, and endometrial cancers  
  • 'Practical considerations 
  • Wrap up 

Target Audience 

This activity has been designed to meet the educational needs of pathologists, laboratory professionals, and other members of the cancer care team. 

Faculty/Authors

Joseph Kim, MD, MPH, MBA
President, Q Synthesis LLC   

Physician's Competency: Patient Care, Medical Knowledge, Practice-Based Learning, and Improvement 

CME/CMLE Credit: 0.5
Estimated Completion Time: 0.5 hour
Format: Online educational activity

Credit Designation Statement

The ASCP designates this activity for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.  

ASCP designates this activity for a maximum of .50 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.  

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT. 


Method of Participation
To complete the activity and receive credit, the participant must complete the online activity. CME certificates will be provided online.
 
Commercial Support
This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc. 

Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Content and click the first module of the course.
  3. Complete the Demographic Survey.
  4. Review the Tweetorial Instructions
  5. Review the Educational Activity.
  6. Submit the course Evaluation.
  7. Enter the maximum number of credits offered and click Claim CME/CMLE to register credit.

Faculty Disclosures 

Technical Considerations 

Release Dates:  8/22/2024   
Review Date:
Expiration Date:  8/22/2027   




Course Objectives

Upon completion of this activity, you will be able to:

  • Identify when HER2 testing may be indicated in patients with advanced gynecologic cancers 

  • Describe how the use of certain HER2-directed therapy may impact clinical outcomes in patients with advanced gynecologic cancers based on HER testing results 

  • Outline how HER2 testing may be performed in different types of advanced gynecologic cancers  

 



 


 

Summary
Availability: On-Demand
Credit Offered:
0.5 CME/CMLE Credit
Contains: 3 Courses
Powered By